GERN Geron Corporation also develops human embryonic stem cell-based therapeutics, with its spinal cord injury treatment. The company has research, development, and commercialization license agreement with Merck & Co., Inc. to use telomerase in non-dendritic cell cancer vaccines.
und
STEM The company engages in product development programs for two cell types: the human neural stem cell and human liver engrafting cells. In its central nervous system Program, the company is conducting a Phase I clinical trial to evaluate the safety and preliminary efficacy of its HuCNS-SC product candidate (purified human neural stem cells) as a treatment for infantile and late infantile neuronal ceroid lipofuscinosis; and in Liver Program, the company is in preclinical development and is continuing to improve processes to isolate and purify its human liver engrafting cells.
----------- Je genauer du planst, umso härter trifft dich der Zufall |